Publications by Mr John Watkinson

Page :

The Management of Squamous Cell Carcinoma of the Neck. The Birmingham UK Experience.

Watkinson JC, Mastronikolis NS, Fitzgerald D, Owen C, Neary Z & Glaholm J.
EJSO April 2005

Is Clinical Otolaryngology publishing patient-centred research?

Bem, C, Lee, C, Dawson, R and Watkinson, JC 2004.
Clin Otolaryngol 29:84-93

Adenoviral delivery of dominant negative fibroblast growth factor receptor 1 blocks FGF effects in thyroid cells and reduces goitrogenesis in mice.

EL Davies, *JD Ramsden, **H Cocks, P Searle, J Watkinson, 1H Ueno, A Logan, JA Franklyn, V Mautner, MC Eggo. 2003.
Journal of Clinical Endocrinology and Metabolism 88:4472-4480

Characterisation of a strain of human thyroid endothelial cells and its interactions with thyroid follicular cells.

Patel V, Logan A, Watkinson JC, Zaman S Uz, Sheppard MC, Ramsden J, Eggo MC.
Am J Physiol 2003. 284 E168-176

Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells.

Cocks H, Thompson S, Turner FE, Logan A, Franklyn JA, Watkinson JC, Eggo MC.
Am J Physiol 2003. 285 E460-469

Adenoviral delivery of dominant negative fibroblast growth factor receptor 1 blocks FGF effects in thyroid cells and reduces goitrogenesis in mice.

Davies EL, Ramsden JD, Cocks H, Turner F, Searle P, Watkinson JC, Ueno H, Logan A, Franklyn JA, Mautner V, Eggo MC.
J Clin Endocrinol Metab. 2003. 88:4472-4480

Isolation and characterization of human thyroid cells in vitro.

Patel VA, Logan A, Watkinson JC, Uz-Zaman S, Sheppard MC, Ramsden JD, Eggo MC 2003.
J Clin Endocrinol Metab 82:2702-9

Conservation Surgery in the Management of T1 and T2 Oropharyngeal Squamous Cell Carcinoma: The Birmingham UK Experience.

Watkinson JC, Thompson S, Owen C, Das Gupta AR, Glaholm J.
Clin Otolaryngol. 2002 27, p541-548.

Who Performs Thyroid Surgery – A Review of Current Otolaryngological Practice.

Ramsden JD, Johnson AP, Cocks HC, Watkinson JC.
Clin. Otolaryngol. 2002. 27, p310-313.

Thyroid follicular cells secrete plasminogen activators and can form angiostatin from plasminogen.

Ramsden JD, Yarram S, Matthews E, Watkinson JC, Eggo MC.
J Endocrinol 2002. 173:475-81

An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings.

Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC and Franklyn JA.
Clin. Endocrinol. 2001 54, 719-723.

Tie 2 is expressed on thyroid follicular cells, is increased in goiter and is regulated by thyrotropin through cyclic adenosine 3’5’-monophosphate.

Ramsden JD, Cocks HC, Shams M, Nijjar S, Watkinson JC, Sheppard MC, Ahmed A, Eggo MC.
J Clin Endocrinol Metab. 2001 Jun;86(6):2709-16.

Thyroid stimulating hormone increased angiogenic growth factor expression in rat thyrocytes.

Cocks HC, Ramsden JD, Watkinson JC, Eggo MC.
Clin Otolaryngol. 2000 Dec;25(6):570-6

Patients’ Preferences in Psychosocial Support on a Head and Neck Oncology Unit.

Owen C, Watkinson JC, and Harrison S.
Psycho-oncology. 2000

Reconstructive techniques currently used following resection of hypopharyngeal carcinoma.

Ayshford CA, Walsh RM, Watkinson JC;
J Laryngol Otol. 1999 Feb;113(2):145-8.

Gender, Clinical Findings, and Serum Thyrotropin Measurements in the Prediction of Thyroid Neoplasia in 1005 Patients Presenting With Thyroid Enlargement and Investigated by Fine-Needle Aspiration Cytology.

Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, and Franklyn JA.
Thyroid, Vol 9. 1999 Thyroid. 11: 1105-1109

Allelic deletion at 8p11.2 is a frequent event in head and neck cancer and identifiable using FISH on tumour imprints.

Kuo MJ, Crundwell MC, Knowles M, Oates J, Watkinson JC, Warfield AT, Morton DG, Neoptolemos JP.
British Journal of Surgery. 1998 85: 1563.

Frequent loss of 5q21 in head and neck cancer without inactivation of the APC gene implies the presence of another putative tumour suppressor gene at 5q21.

Kuo MJ, Mackay SJ, Oates J, Warfield AT, Watkinson JC, Morton DG, Neoptolemos JP.
British Journal of Surgery. 1998 85: 1575.

Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.

Thompson SD, Franklyn JA*, Watkinson JC*, Verhaeg JM, Sheppard MC*, Eggo MC*.
Journal of Clinical Endocrinology and Metabolism 1998;83 (4): 1336-1341

Page :